First discovered by Friedenstein in 1976, mesenchymal stem cells (MSCs) are adult stem
cells found throughout the body that share a fixed set of characteristics. Discovered initially …

In recent years, there has been a tremendous development of biotechnological,
pharmacological, and medical techniques which can be implemented in the functional …

The stem cell-based therapy has emerged as a promising therapeutic strategy for treating
cardiovascular ischemic diseases (CVIDs), such as myocardial infarction (MI). However …

Mesenchymal stem cell (MSC) transplantation is promising for repairing heart tissues post
myocardial infarction (MI). In particular, paracrine effects of the transplanted MSCs have …

Mesenchymal stromal cells (MSCs) are widely used in the clinic because they involve fewer
ethical issues and safety concerns compared to other stem cells such as embryonic stem …

Due to their robust immunomodulatory capabilities, mesenchymal stem/stromal cells (MSCs)
have been used as a cellular therapy for a number of human diseases. Part of the …

Conventional tissue engineering, cell therapy, and current medical approaches were shown
to be successful in reducing mortality rate and complications caused by cardiovascular …

Acute myocardial infarction (MI) is a common cardiovascular disease with high mortality. In
this study, an injectable thermosensitive hydrogel of chitosan (CS)/dextran (DEX)/β …

Radiation-induced lung injury (RILI) is a common complication in radiotherapy of thoracic
tumors and limits the therapeutic dose of radiation that can be given to effectively control …

The stem cell-based therapy has emerged as the promising therapeutic strategies for
cardiovascular diseases (CVDs). Recently, increasing evidence suggest stem cell-derived …